Methodological challenges in utilizing miRNAs as circulating biomarkers.
Moldovan L, Batte KE, Trgovcich J, Wisler J, Marsh CB, Piper M. · 2014
Read Methodological challenges in utilizing miRNAs as circulating biomarkers. by Moldovan L, Batte KE, Trgovcich J, Wisler J, Marsh CB, Piper M. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3943687.txt.
Description
Leni Moldovan and five colleagues warn that blood microRNA tests rest on shaky method ground. Their paper appeared in the Journal of Cellular and Molecular Medicine in 2014. MicroRNAs are short molecules that tune gene activity. They escape from tissues into blood, urine, and spinal fluid. Their levels shift in disease. That makes them tempting as markers. But early studies often disagree with each other.
The authors trace much of the strife to technique. They draw on work in heart and lung disease. Each step gets scrutiny. How blood is drawn and handled is one step. How the tiny RNAs are pulled from plasma or serum is next. How levels are profiled is the third. At each step, small choices can bend results. The message is blunt. Method rigor must come first, before these markers can serve in diagnosis.
Catalog record
| CREATOR | Moldovan L, Batte KE, Trgovcich J, Wisler J, Marsh CB, Piper M. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 92 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |